Eton Pharmaceuticals (ETON)CEO sold ~$1.06M
Sean Brynjelsen, CEO at Eton Pharmaceuticals, sold ~$1.06M of Eton Pharmaceuticals shares.
- ~$1.06M
- Approx. value · 61K sh @ $17.38
- 3.02M
- Holds after · shares reported
- Traded
- Jun 3, 2025
- Filed
- Jun 5, 2025
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Jun 3, 2025 · this disclosureInsiderCEO sold ~$1.06M of ETON shares in the open market
What came next
- Jun 3, 2025Insider · 1 personInsiders: 2 sales (~$167K)
- Jun 4, 2025InsiderCEO sold ~$1.19M of ETON shares in the open market
- Jun 5, 2025InsiderCEO sold ~$1.18M of ETON shares in the open market
- Jun 10, 2025Insider · 1 personInsiders: 2 purchases (~$125K)
- Jun 12, 2025InsiderOfficer sold ~$253K of ETON shares in the open market
- Jun 13, 2025InsiderOfficer sold ~$100K of ETON shares in the open market
- Jun 16, 2025InsiderOfficer sold ~$151K of ETON shares in the open market
- Aug 19, 2025InsiderCFO sold ~$632K of ETON shares in the open market
- Aug 20, 2025InsiderCFO sold ~$42K of ETON shares in the open market
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Eton Pharmaceuticals
For Eton Pharmaceuticals, OQRO holds 2 insider filings (SEC Form 4 or Form 144) and 1 fund holdings report (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ETON page.
Other recent filings by Sean Brynjelsen, President & CEO
- SEC Form 4 at Eton Pharmaceuticals (ETON)Jun 5, 2025
- SEC Form 4 at Eton Pharmaceuticals (ETON)Jun 5, 2025
- SEC Form 4 at Eton Pharmaceuticals (ETON)Jun 5, 2025
- SEC Form 4 at Eton Pharmaceuticals (ETON)Jun 5, 2025
The full history of Sean Brynjelsen, President & CEO is on the profile page.
How this filing works
Other disclosures at Eton Pharmaceuticals
- SEC Form 4Oct 7, 2026
- SEC Form 144Oct 6, 2026
- SEC Form 13F-HRAug 14, 2026
- SEC Form 13F-HRMay 15, 2026
- SEC Form 13F-HRFeb 17, 2026
- SEC Form 13F-HRFeb 17, 2026
Everything OQRO holds on this company is on its ETON page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
